S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
3 Free Stock Picks per Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Buy THIS stock before Taiwan is attacked (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
3 Free Stock Picks per Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Buy THIS stock before Taiwan is attacked (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
3 Free Stock Picks per Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Buy THIS stock before Taiwan is attacked (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
3 Free Stock Picks per Day (Ad)
Biden and GOP rush to finalize debt ceiling deal, shore up support to prevent default
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Sell every Stock except ONE (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
'Succession' fans brace for series finale of Emmy-winning hit drama
Buy THIS stock before Taiwan is attacked (Ad)
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Forecast, Price & News

$1.25
0.00 (0.00%)
(As of 05/26/2023 ET)
Compare
Today's Range
$1.25
▼
$1.25
50-Day Range
$1.03
▼
$1.51
52-Week Range
$0.77
▼
$1.59
Volume
N/A
Average Volume
60 shs
Market Capitalization
$813.88 million
P/E Ratio
31.20
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsHeadlinesShort Interest

PHGUF stock logo

About Pharming Group (OTCMKTS:PHGUF) Stock

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Stock News Headlines

May 15, 2023 | markets.businessinsider.com
RBC Capital Sticks to Their Buy Rating for Pharming Group (PHGUF)
May 12, 2023 | msn.com
Pharming Group N.V. GAAP EPS of $0.02, revenue of $42.5M misses by $6M
May 28, 2023 | Stocks To Trade (Ad)
Free A.I. Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
May 11, 2023 | benzinga.com
Pharming Group shares are trading lower after the company reported a year-over-year decrease in Q1 EPS and revenue.
May 11, 2023 | markets.businessinsider.com
Pharming Group NV American Depositary Shares Repr 10 earnings: here's what Wall Street expects
May 11, 2023 | finance.yahoo.com
Pharming Group reports financial results for the first quarter of 2023
May 8, 2023 | finance.yahoo.com
Pharming Group's (AMS:PHARM) investors will be pleased with their decent 51% return over the last year
April 30, 2023 | americanbankingnews.com
Pharming Group (OTCMKTS:PHGUF) Short Interest Up 22.8% in April
May 28, 2023 | Behind the Markets (Ad)
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
April 26, 2023 | finanznachrichten.de
Pharming Group N.V.: Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
April 26, 2023 | finance.yahoo.com
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
April 19, 2023 | finanznachrichten.de
Pharming Group: Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023
April 19, 2023 | finanznachrichten.de
Pharming Group N.V.: Notice of First Quarter 2023 Results
April 19, 2023 | finance.yahoo.com
Notice of First Quarter 2023 Results
April 19, 2023 | finance.yahoo.com
Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023
April 11, 2023 | finance.yahoo.com
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
April 5, 2023 | finance.yahoo.com
Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
March 30, 2023 | finance.yahoo.com
Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days
March 27, 2023 | finance.yahoo.com
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
March 13, 2023 | finance.yahoo.com
Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
February 28, 2023 | finanznachrichten.de
Pharming Group N.V.: Notice of Full Year 2022 financial results
February 28, 2023 | finance.yahoo.com
Notice of Full Year 2022 financial results
February 21, 2023 | finanznachrichten.de
Pharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
January 9, 2023 | finance.yahoo.com
Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 49% Above Its Share Price
December 19, 2022 | finance.yahoo.com
Pharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
December 15, 2022 | finance.yahoo.com
Pharming Highlights Interim Data From Rare Immune Deficiency Study
December 15, 2022 | finance.yahoo.com
Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition
See More Headlines
Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Company Calendar

Last Earnings
3/05/2015
Today
5/28/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PHGUF
Previous Symbol
OTC:PHGUF
CUSIP
N/A
CIK
N/A
Web
www.pharming.com
Phone
(171) 524-7400
Fax
31-0-71-524-7445
Employees
277
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.04
Trailing P/E Ratio
31.20
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$16 million
Net Margins
14.90%
Pretax Margin
N/A
Return on Equity
15.52%
Return on Assets
7.77%

Debt

Debt-to-Equity Ratio
0.68
Current Ratio
5.40
Quick Ratio
4.68

Sales & Book Value

Annual Sales
$198.87 million
Price / Sales
4.09
Cash Flow
$0.06 per share
Price / Cash Flow
21.93
Book Value
$0.31 per share
Price / Book
4.02

Miscellaneous

Outstanding Shares
652,410,000
Free Float
N/A
Market Cap
$813.88 million
Optionable
Not Optionable
Beta
1.09

Key Executives

  • Sijmen de Vries
    Chief Executive Officer & Executive Director
  • Mireille Sanders
    Chief Operations Officer
  • Jeroen Henk Wakkerman
    Chief Financial Officer
  • Robert Friesen
    Chief Scientific Officer
  • Anurag Relan
    Chief Medical Officer

Key Competitors

View All Competitors













PHGUF Stock - Frequently Asked Questions

How have PHGUF shares performed in 2023?

Pharming Group's stock was trading at $1.1499 on January 1st, 2023. Since then, PHGUF stock has increased by 8.5% and is now trading at $1.2475.
View the best growth stocks for 2023 here.

Are investors shorting Pharming Group?

Pharming Group saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,456,400 shares, an increase of 38.0% from the April 15th total of 4,679,100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 64,564.0 days.
View Pharming Group's Short Interest.

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) announced its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a trailing twelve-month return on equity of 15.52% and a net margin of 14.90%.

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How do I buy shares of Pharming Group?

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.25.

How much money does Pharming Group make?

Pharming Group (OTCMKTS:PHGUF) has a market capitalization of $813.88 million and generates $198.87 million in revenue each year. The biotechnology company earns $16 million in net income (profit) each year or $0.04 on an earnings per share basis.

How many employees does Pharming Group have?

The company employs 277 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The official website for the company is www.pharming.com. The biotechnology company can be reached via phone at (171) 524-7400, via email at investor@pharming.com, or via fax at 31-0-71-524-7445.

This page (OTCMKTS:PHGUF) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -